Search
Now showing items 1-10 of 21
Mergers, Acquisitions, and Alliances
(The Oxford Handbook of the Economics of the Biopharmaceutical Industry, 2012-09-18)
© 2012 by Oxford University Press. All rights reserved.This article considers the
determinants and effects of M&As in the pharmaceutical industry, with a particular
focus on innovation and R&D productivity. As is the case ...
R&D Costs and Returns to New Drug Development: A Review of the Evidence
(The Oxford Handbook of the Economics of the Biopharmaceutical Industry, 2012-09-18)
© 2012 by Oxford University Press. All rights reserved.This article reviews the extensive
literature on R&D costs and returns. The first section focuses on R&D costs and the
various factors that have affected the trends ...
Structural Effects of Regulation on Innovation in the Ethical Drug Industry
(Essays on industrial organization, in honor of Joe S. Bain, 1976)
Pressures from the Demand Side: Changing Market Dynamics and Industrial Structure
(Consolidation and Competition in the Pharmaceutical Industry, 2001)
Graph-Oriented Model for Research Management
(Research program effectiveness. Proceedings of the conference sponsored by the Office
of Naval Research, Washington, D.C., July 27-29, 1965. Edited by M. C. Yovits [and
others], etc, 1966)
Impact of Public Policy on Drug Innovation and Pricing
(Impact of Public Policy on Drug Innovation and Pricing, 1976)
Innovation and International Competitiveness in Pharmaceuticals
(Evolving Technology and Market Structure: Studies in Schumpeterian Economics, 1990)
Encouraging innovative treatment of neglected diseases through priority review vouchers
(Prescribing Cultures and Pharmaceutical Policy in the Asia-Pacific, 2009-09-01)
A Computer Simulation Model of Pharmaceutical Innovation
(Pharmaceutical Economics, 1984)
Increasing R&D Incentives for Neglected Diseases: Lessons from the Orphan Drug Act
(International Public Goods And Transfer Of Technology Under A Globalized Intellectual
Property Regime, 2005)